Sepsis-induced myocardial dysfunction

被引:117
|
作者
Walley, Keith R. [1 ]
机构
[1] Univ British Columbia, Ctr Heart Lung Innovat, Div Crit Care Med, Vancouver, BC, Canada
基金
加拿大健康研究院;
关键词
contractility; diastolic dysfunction; intramyocardial inflammation; myocardial dysfunction; septic shock; SEPTIC SHOCK; VENTRICULAR CONTRACTILITY; CARDIAC DYSFUNCTION; OXYGEN DELIVERY; MORTALITY; LEVOSIMENDAN; ENDOTOXEMIA; DEPRESSION; RECEPTOR; ICAM-1;
D O I
10.1097/MCC.0000000000000507
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Purpose of reviewSepsis leads to a complex intramyocardial inflammatory response that results in sepsis-induced myocardial dysfunction. Here, recent findings are reviewed in a physiologic context.Recent findingsDecreased systolic contractility during sepsis limits ventricular ejection and stroke volume. Initially, this effect is compensated for by increased diastolic filling during volume resuscitation. Reduced afterload due to arterial vasodilation also compensates so that cardiac output can be maintained or increased. Recent results recognize the importance of diastolic dysfunction, reduced ventricular diastolic compliance that impedes ventricular filling. Diastolic dysfunction becomes increasingly important as severity of septic shock increases. When impaired ventricular ejection is coupled with limited diastolic filling, stroke volume must decrease. Accordingly, diastolic dysfunction is more closely related to mortality than systolic dysfunction. Recent trials of beta-adrenergic agonists and levosimendan have been disappointing, while approaches to modulating the intramyocardial inflammatory response show promise.SummarySepsis-induced myocardial dysfunction is increasingly recognized as a major contributor to outcome of septic shock. Significant strides have been made in understanding the intramyocardial inflammatory response that causes myocardial dysfunction. A number of novel approaches show promise by modulating the intramyocardial inflammatory response.
引用
收藏
页码:292 / 299
页数:8
相关论文
共 50 条
  • [1] Sepsis-induced myocardial dysfunction
    Sharma, A. C.
    [J]. SHOCK, 2006, 25 : 14 - 15
  • [2] Sepsis-induced myocardial dysfunction
    Sharma, Avadhesh C.
    [J]. SHOCK, 2007, 28 (03): : 265 - 269
  • [3] Pathophysiology of sepsis-induced myocardial dysfunction
    Xiu-Xiu Lv
    Hua-Dong Wang
    [J]. Military Medical Research, 2016, 3 (04) : 202 - 211
  • [4] Pathophysiology of sepsis-induced myocardial dysfunction
    Lv X.
    Wang H.
    [J]. Military Medical Research, 3 (1)
  • [5] Sepsis-induced myocardial dysfunction: the role of mitochondrial dysfunction
    Hang Yang
    Zhaocai Zhang
    [J]. Inflammation Research, 2021, 70 : 379 - 387
  • [6] Sepsis-induced myocardial dysfunction: the role of mitochondrial dysfunction
    Yang, Hang
    Zhang, Zhaocai
    [J]. INFLAMMATION RESEARCH, 2021, 70 (04) : 379 - 387
  • [7] Sepsis-induced myocardial dysfunction: Pathophysiology and management
    Kakihana Y.
    Ito T.
    Nakahara M.
    Yamaguchi K.
    Yasuda T.
    [J]. Journal of Intensive Care, 4 (1)
  • [8] Sepsis-Induced Myocardial Dysfunction "Right Ventricular Dysfunction" or "Biventricular Dysfunction"?
    Pal, Nirvik
    Lim, Aaron
    Karamchandani, Kunal
    [J]. CHEST, 2021, 159 (04) : 1684 - 1685
  • [9] Sepsis-induced myocardial dysfunction: Linking physiology and genomics
    Cohen, Rubin I.
    [J]. CRITICAL CARE MEDICINE, 2010, 38 (03) : 1001 - 1002
  • [10] Sepsis-Induced Myocardial Dysfunction: Another Piece in the Puzzle
    Parker, Margaret M.
    [J]. PEDIATRIC CRITICAL CARE MEDICINE, 2016, 17 (05) : 457 - 458